Patrick Shannon, MD
Dermatology · Boardman, OHNPI 1316933260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 378 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.
Across 378 payments — averaging $27.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- Incyte Corporation$899
- Journey Medical Corporation$853
- E.r. Squibb & Sons, L.L.C.$764
- Dermavant Sciences, Inc.$548
- plus $4K from 30 others
Across 531 payments — averaging $3830.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$611K
- Eli Lilly$362K
- Incyte Corporation$201K
- Acrotech Biopharma Inc.$177K
- Amgen$168K
- Novartis$157K
- plus $357K from 4 others
What the payments were for
- Food & beverage$10,15297%
- Education$3573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 119 | $2,138 |
| AbbVie(2 entities) | 60 | $1,146 |
| Incyte Corporation | 13 | $899 |
| Journey Medical Corporation | 13 | $853 |
| E.r. Squibb & Sons, L.L.C. | 23 | $764 |
| Dermavant Sciences, Inc. | 10 | $548 |
| Sun Pharmaceutical Industries Inc. | 10 | $525 |
| Sanofi | 12 | $439 |
| Novartis | 29 | $415 |
| LEO Pharma Inc. | 11 | $343 |
| Janssen Scientific Affairs, LLC | 6 | $308 |
| Lilly USA, LLC | 8 | $284 |
| Arcutis Biotherapeutics, Inc. | 10 | $276 |
| UCB, Inc. | 7 | $227 |
| Sanofi-aventis U.S. LLC | 2 | $142 |
| Biofrontera Inc. | 2 | $138 |
| Galderma Laboratories, L.p. | 3 | $137 |
| Amgen | 4 | $122 |
| Organon | 7 | $113 |
| Organogenesis Inc. | 3 | $100 |
| Convatec Inc. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $74 |
| Chiesi USA, Inc. | 2 | $64 |
| Verrica Pharmaceuticals Inc. | 2 | $57 |
| Pfizer | 3 | $45 |
| Mayne Pharma Commercial LLC | 2 | $42 |
| Botanix SB Inc | 2 | $36 |
| Janssen Research & Development, LLC | 1 | $32 |
| Genentech USA, Inc. | 2 | $28 |
| Eli Lilly | 1 | $25 |
| Krystal Biotech Inc | 1 | $22 |
| Revance Therapeutics, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Mimedx Group, Inc. | 1 | $18 |
| Dermira, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,510 in reported general payments places this provider in the 80th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $49,618 |
| Dupixent SyringeDupilumab | 12 | $42,170 |
| Clobetasol Propionate | 120 | $7,010 |
| Fluorouracil | 68 | $5,905 |
| Metronidazole | 35 | $2,685 |
| Ketoconazole | 129 | $2,175 |
| Triamcinolone Acetonide | 184 | $1,773 |
| Doxycycline Hyclate | 118 | $1,592 |
| Fluocinonide | 49 | $1,589 |
| ValacyclovirValacyclovir Hcl | 46 | $1,488 |
| Gentamicin Sulfate | 21 | $1,130 |
| Hydroxychloroquine Sulfate | 24 | $1,003 |
| MethotrexateMethotrexate Sodium | 35 | $975 |
| Clindamycin Phosphate | 24 | $953 |
| Minocycline Hcl | 43 | $811 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boardman
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
- Dawn MerrittAthens$844K
- Neil KormanCleveland$824K
- Joshua GrosshandlerWesterville$479K
- Lorie GottwaldToledo$460K
- Gregory DelostMayfield Heights$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.